Discover how alternative splicing defects in Relapsing-Remitting Multiple Sclerosis create dysfunctional proteins that drive autoimmune attacks on the nervous system.
Discover how protein biomarker fingerprints are revolutionizing multiple sclerosis diagnosis, relapse prediction, and treatment personalization.